Cell MedX Corp. (OTCMKTS:CMXC) Short Interest Up 7,100.0% in September

Cell MedX Corp. (OTCMKTS:CMXC) saw a large increase in short interest during the month of September. As of September 30th, there was short interest totalling 7,200 shares, an increase of 7,100.0% from the September 15th total of 100 shares. Based on an average trading volume of 39,500 shares, the days-to-cover ratio is presently 0.2 days.

OTCMKTS CMXC opened at $0.20 on Thursday. Cell MedX has a 12 month low of $0.18 and a 12 month high of $0.46. The company has a 50-day moving average of $0.22 and a 200-day moving average of $0.24.

About Cell MedX

Cell MedX Corp. is a biotech company, which engages in the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness. Its products include microcurrent therapy and eBalance systems. The company was founded on March 19, 2010 and is headquartered in Carson City, NV.

Featured Article: Learning About the VIX – Volatility Index

Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.